Showing 15 posts of 788 posts found.


UK MPs call for Brexit priority over pharma industry

May 17, 2018
Medical Communications ABPI, UK government, biotech, drugs, pharma, pharmaceutical

A new report published by the Business, Energy and Industrial Strategy Committee has called for the UK government to ensure …


Roche gets NICE approval for advanced bladder cancer

May 17, 2018
Sales and Marketing Roche, biotech, drugs, pharma, pharmaceutical, tecentriq

Though trial results for Tecentriq (atezolizumab) may not necessarily be going Roche’s way, after a combination treatment failure, the treatment …


How to treat colds? Target the person, not the virus

May 15, 2018
Research and Development biotech, common cold, drugs, pharma, pharmaceutical

Researchers from Imperial College London have discovered how to interfere with one of the building blocks that allows the common …


FDA issues warning letter over potential for poisoning at India plant

May 15, 2018
Manufacturing and Production FDA, India, biotech, drugs, pharma, pharmaceutical

The FDA has noted a number of failings at a plant in Gujarat, India, but mostly significantly was the finding …


Smell test targets asymptomatic malaria carriers

May 15, 2018
Manufacturing and Production, Research and Development biotech, drugs, malaria, pharma, pharmaceutical

Asymptomatic carriers of malaria may be responsible for the onwards transmission of up to 90% of cases, highlighting the importance …


Emergex secures funds in race to develop universal flu vaccine

May 15, 2018
Manufacturing and Production, Sales and Marketing Emergex, Innovate UK, biotech, drugs, influenza vaccine, pharma, pharmaceutical

UK-based biotech, Emergex Vaccines, has received £1 million to push its universal flu vaccine through preclinical tests, in the hope …

Takeda financials show why the Shire deal was needed

May 14, 2018
Sales and Marketing Shire, Takeda, biotech, drugs, pharma, pharmaceutical

After posting its financials from 2017 and its guidance for the year to come, it’s clear to see why Takeda …


Pharma unfazed by Trump price-reduction proposals

May 14, 2018
Medical Communications, Sales and Marketing PhRMA, President trump, biotech, drugs, pharma, pharmaceutical

President Trump’s speech on Friday afternoon had been long-anticipated, ever since he was elected and then hammered the pharma industry …

AZ’s Fasenra stumbles in P3 for COPD

May 11, 2018
Medical Communications, Research and Development AstraZeneca, Fasenra, GSK, Nucala, biotech, drugs, pharma, pharmaceutical

AstraZeneca’s Fasenra arrived later on the scene than GSK rival med, Nucala, and so it needed to quickly rack up …


C4 Therapeutics fills out C-Suite with CEO appointment

May 10, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing C4 Therapeutics, biotech, drugs, pharma, pharmaceutical

C4 Therapeutics has been slowly expanding since its creation in early 2016 out of the prestigious Dana-Farber Cancer Institute. Andrew …


Lilly moves quickly to secure $1.6bn buyout of Armo

May 10, 2018
Medical Communications, Sales and Marketing Armo Biosciences, Eli Lilly, biotech, drugs, pharma, pharmaceutical

Armo BioSciences only went public in January but it has already been snapped up by Eli Lilly for $1.6 billion. …


Lodo and Roche go digging for drug candidates, after $1bn deal

May 10, 2018
Sales and Marketing Genentech, Roche, biotech, drugs, pharma, pharmaceutical

Discovering potential therapeutics from natural sources has been a constant throughout the evolution of medicine, Lodo Therapeutics, however, has taken …

Novartis’ $1.2m payment to Trump’s lawyer raises more questions than answers

May 10, 2018
Medical Communications Essential Consultants, Michael Cohen, Novartis, President trump, Trump, biotech, drugs, pharma, pharmaceutical

Novartis payment to President Trump’s personal lawyer, Michael Cohen, had seemed fairly odd from the beginning – with many asking …

GSK’s CFO chooses to exit company

May 9, 2018
Medical Communications GSK, biotech, drugs, pharma, pharmaceutical

Simon Dingemans has been Chief Financial Officer at GSK since 2011 but has now chosen to retire from the position …

Latest content